| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Common Stock | Sale | -$140K | -2.8K | -0.61% | $50.16 | 460K | Nov 11, 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | -$160K | -3.2K | -0.7% | $50.09 | 457K | Nov 11, 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | -$210K | -4.2K | -0.92% | $50.03 | 453K | Nov 11, 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | -$310K | -6.2K | -1.37% | $50.06 | 446K | Nov 11, 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | -$456K | -9.1K | -2.04% | $50.14 | 437K | Nov 11, 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | -$476K | -9.5K | -2.17% | $50.15 | 428K | Nov 11, 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | -$492K | -9.82K | -2.3% | $50.07 | 418K | Nov 11, 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | -$586K | -11.7K | -2.8% | $50.10 | 406K | Nov 11, 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | -$777K | -15.5K | -3.82% | $50.12 | 391K | Nov 11, 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | -$1.51M | -30.2K | -7.73% | $50.02 | 360K | Nov 11, 2021 | Direct | |
| transaction | PFE | Common Stock | Sale | -$2.39M | -47.8K | -13.25% | $50.01 | 313K | Nov 11, 2021 | Direct | |
| holding | PFE | Common Stock | 2.55K | Nov 11, 2021 | By Rule 16b-3 Plan | ||||||
| holding | PFE | Common Stock | 1.62K | Nov 11, 2021 | By Trustee under the Pfizer Share Ownership Plan |